Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BioXcel Therapeutics
Biotech
Jay Bradner returns to lead R&D at Amgen—Chutes & Ladders
Bradner returns from brief break to lead Amgen R&D. Genentech's interim CEO given the permanent job. Moderna ousts commercial chief Garay.
Max Bayer
,
Gabrielle Masson
Dec 15, 2023 9:30am
BioXcel to halve head count, narrow R&D as cash runway crumbles
Aug 14, 2023 8:44am
BioXcel’s oncology spinout OnkosXcel sets out for ‘surprise’ IPO
Mar 15, 2023 11:51am
BioXcel teases phase 2 Keytruda combination trial data drop
Jan 11, 2023 9:45am
BioXcel enters $260M finance deal–but terms apply
Apr 20, 2022 9:30am
Once-failed cancer drug ramps up I-O in pancreatic cancer models
Nov 8, 2021 10:00am
